In summary, as shown in Fig. 8, BEL ameliorated cardiac hypertrophy and promoted cardiac function, making it a potential drug to target the BRD4/Nox4/ROS signalling pathway. This evidence concerns the gene BRD4 and cardiac hypertrophy.